Celecoxib is as effective as other NSAIDs
The newly developed COX 2 specific inhibitor, celecoxib, is as
effective as other non-steroidal inflammatory drugs (NSAIDs) for
controlling symptoms of osteoarthritis and rheumatoid arthritis but
causes fewer gastrointestinal complications. These findings are
supported by the results of a systematic review of randomised trials
carried out by Deeks and colleagues (p 619). Other non-steroidal anti-inflammatory drugs are commonly prescribed for patients with arthritis but their long term use has been associated with the development of serious gastrointestinal problems.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
StumbleUpon 
Technorati What's this?
Relevant Article
- Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials
- Jonathan J Deeks, Lesley A Smith, and Matthew D Bradley
BMJ 2002 325: 619.[Abstract] [Full Text] [PDF]
This Article
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Related Content
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
There are no rapid responses for this article. Print issues
